Related Experiment Video
Updated: Jan 16, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
From lab to environment: forecasting pharmaceutical impact using in silico and analytical tools
Hamza Boucetta1,2,3, Peije Russell1, David Rudd1,2,3
1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University Parkville Victoria 3052 Australia David.Rudd@monash.edu.
Pharmaceuticals contaminate the environment, posing ecological risks. This review explores predictive tools like in silico modeling and analytical methods for early environmental risk assessment in drug development.
Area of Science:
- Environmental Chemistry
- Pharmaceutical Science
- Ecotoxicology
Background:
- Pharmaceuticals are prevalent environmental contaminants, exceeding safe levels for aquatic ecosystems.
- Current monitoring methods are reactive, detecting pollution after environmental release.
- There is a critical need for predictive tools to assess environmental risks early in drug development.
Purpose of the Study:
- To review current and emerging strategies for early screening of pharmaceutical environmental fate.
- To emphasize the integration of predictive tools into the pharmaceutical design pipeline.
Main Methods:
- In silico approaches: Quantitative Structure-Activity Relationship (QSAR) modeling, machine learning, molecular docking.
- Analytical techniques: High-Performance Liquid Chromatography (HPLC), Nuclear Magnetic Resonance (NMR), LC/GC-MS, Ion Mobility Spectrometry (IMS).
- Utilizing these methods for validating predictions and characterizing environmental samples.
Main Results:
- In silico and analytical methods provide a proactive framework for environmental risk assessment.
- These tools enable early screening of pharmaceutical persistence, toxicity, and bioaccumulation.
- The combined approach facilitates the integration of environmental considerations into drug development.
Conclusions:
- Predictive tools are essential for mitigating the ecological impact of pharmaceuticals.
- Integrating early environmental risk assessment into drug design is crucial for sustainability.
- A proactive strategy using in silico and analytical methods enhances pharmaceutical development and environmental protection.
More Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Drug Discovery: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Product Performance: In Vitro–In Vivo Correlation
In Vitro Drug Release Testing: Overview, Development and Validation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Preclinical Development: Overview